Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kezar Life Sciences (KZR) Short term Debt (2024 - 2025)

Kezar Life Sciences' Short term Debt history spans 2 years, with the latest figure at $5.3 million for Q3 2025.

  • For Q3 2025, Short term Debt rose 34.91% year-over-year to $5.3 million; the TTM value through Sep 2025 reached $5.3 million, up 34.91%, while the annual FY2024 figure was $5.2 million, N/A changed from the prior year.
  • Short term Debt for Q3 2025 was $5.3 million at Kezar Life Sciences, roughly flat from $5.3 million in the prior quarter.
  • Across five years, Short term Debt topped out at $5.3 million in Q2 2025 and bottomed at $1.3 million in Q1 2024.